quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:17:14·58d
PRRelease
Larimar Therapeutics Inc. logo
Meta Platforms Inc. logo
Vir Biotechnology Inc. logo

Biotech and Big Tech Drive the Morning Narrative

LRMR· Larimar Therapeutics Inc.META· Meta Platforms Inc.VIR· Vir Biotechnology Inc.
Health CareTechnology
Original source

Companies

  • LRMR
    Larimar Therapeutics Inc.
    Health Care
  • META
    Meta Platforms Inc.
    Technology
  • VIR
    Vir Biotechnology Inc.
    Health Care

Recent analyst ratings

  • Apr 10METAUpdateWolfe Research$800.00
  • Apr 9METAUpdateRosenblatt$1,015
  • Apr 3METAUpdateErste Group-
  • Apr 2METAUpdateErste Group-
  • Mar 30METAUpdateMorgan Stanley$775.00
  • Mar 5METAUpdateArete-

Related

  • PR12h
    Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
  • INSIDER1d
    SEC Form 4 filed by Olivan Javier
  • SEC2d
    SEC Form PX14A6G filed by Meta Platforms Inc.
  • SEC3d
    SEC Form DEF 14A filed by Larimar Therapeutics Inc.
  • INSIDER6d
    SEC Form 4 filed by Kimmitt Robert M
  • SEC7d
    SEC Form DEFA14A filed by Meta Platforms Inc.
  • SEC7d
    SEC Form DEF 14A filed by Meta Platforms Inc.
  • SEC7d
    SEC Form DEFA14A filed by Vir Biotechnology Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022